NASDAQ:ALBO - Albireo Pharma, Inc.
$28.21
 $-0.01
-0.02%
11:55AM EDT
2019-07-22
Albireo Pharma, Inc., formerly Biodel Inc., incorporated on December 8, 2003, is a specialty biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI), disorders where improper flow or absorption of bile causes medical conditions for which there is unmet need. The target indication for its lead product candidate, A4250, is progressive familial intrahepatic cholestasis (PFIC), which is a genetic disorder affecting children. Other products in the Company's pipeline include Elobixibat, A3384 and Bile Acid Modulators.A4250A4250 is a potent and selective inhibitor of intracapsular brown adipose tissue (IBAT) that is designed to reduce bile acid reabsorption from the small intestine to the liver, leading to reduced levels of bile acids in the serum and liver and increased excretion of bile acids via the colon. A4250 is being evaluated in a Phase II clinical trial in children with chronic cholestasis. In addition to PFIC and subject to obtaining additional capital, the Company focuses on conducting clinical development of A4250 as a treatment for other pediatric cholestatic liver diseases and disorders.ElobixibatElobixibat is indicated for the treatment of chronic constipation. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ALBO     avg for
industry  
  avg for
sector  
42 stocks weight:  26. 13   217. 37   399. 45  
42 stocks rank:  2. 97 K 1. 27 K 716. 99  
# analyst opinions:  7. 00   13. 21   13. 71  
mean recommendation:  1. 50   2. 10   2. 04  

quick ratio:  15. 40   5. 49   1. 88  
current ratio:  15. 53   5. 87   2. 36  

target price low:  41. 00   83. 44   114. 90  
target price avg:  63. 43   106. 20   137. 90  
target price high:  27. 69   132. 30   158. 97  
1-yr high:  37. 86   111. 86   142. 57  
last close:  28. 22   86. 79   125. 44  
50-day avg:  32. 43   86. 68   122. 63  
200-day avg:  29. 02   89. 22   121. 38  
1-yr low:  20. 90   69. 78   100. 51  
volume:  32. 97 K 2. 62 M 3. 43 M
50-day avg volume:  72. 63 K 3. 20 M 4. 16 M
200-day avg volume:  47. 04 K 2. 99 M 4. 75 M

1-day return:  -2. 82 % -1. 30 % -0. 99 %
this week return:  -0. 74 % 0. 45 % -0. 20 %
12-wk return:  -14. 74 % 0. 94 % 4. 84 %
52-wk return:  -10. 15 % -1. 30 % 10. 55 %

enterprise value (EV):  189. 80 M 45. 10 B 122. 38 B
market cap:  339. 75 M 38. 96 B 108. 40 B
EBITDA:  -52. 65 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -3. 60   5. 38   11. 93  
enterprise/revenue (EV/R):  90. 04   57. 92   10. 21  
total revenue:  2. 11 M 9. 91 B 39. 98 B
total debt:  387. 00 K 10. 90 B 17. 48 B
debt/equity:  0. 35   57. 18   120. 05  
net income (common):  -61. 15 M 2. 07 B 4. 05 B

shares outstanding:  12. 04 M 538. 09 M 1. 24 B
shares:  6. 89 M 548. 00 M 1. 22 B
shares short:  546. 73 K 10. 98 M 11. 87 M
shares short prior month:  504. 56 K 9. 32 M 12. 05 M
short ratio:  7. 88   5. 60   3. 34  
short % of float:  5. 34 % 6. 48 % 2. 64 %
total cash/share:  12. 49   10. 98   9. 19  
total cash:  150. 34 M 5. 93 B 6. 10 B
free cash flow:  -29. 23 M 2. 92 B 4. 55 B
operating cash flow:  -41. 42 M 3. 80 B 5. 78 B

book value:  9. 25   13. 35   27. 45  
price/book:  3. 05   4. 60   8. 78  
gross profits:  12. 74 M 7. 44 B 36. 13 B
operating margins:  -2497. 96 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  100. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -5. 11   2. 10   4. 23  
forward EPS:  -5. 37   3. 45   7. 10  
P/E:  -5. 53   1. 90   32. 10  
forward P/E:  -5. 26   6. 46   15. 47  
PE/G:  0. 06   0. 70   -0. 54  
growth:  -94. 90 % 265. 63 % 79. 11 %
earnings high:  -1. 33   0. 89   1. 68  
earnings avg:  -1. 43   0. 70   1. 57  
earnings low:  -1. 61   0. 46   1. 46  
revenue high:  1. 50 M 2. 57 B 11. 07 B
revenue avg:  770. 00 K 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -17. 06 % -2. 34 % 5. 28 %
return on equity:  -45. 04 % -90. 08 % 133. 53 %
revenue growth:  -94. 90 % 265. 25 % 73. 68 %
revenue/share:  0. 18   12. 72   60. 04  

beta (1yr vs S&P500):  1. 62   1. 27   0. 91  
sharpe (1yr):  -0. 02   0. 16   0. 77  

held % insiders:  12. 29 % 6. 06 % 3. 29 %
held % institutions:  75. 75 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ALBO
.    138.196 =       138.196 :: --> INITIAL WEIGHT <--
.    - 5.105 =       133.091 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.134 =       283.977 :: P/E factor
.    x 2.036 =       578.043 :: PE/G factor
.    x 1.508 =       871.834 :: beta factor
.    x 0.646 =       562.803 :: sharpe factor
.    x 2.646 =      1489.016 :: current ratio factor
.    x 1.034 =      1539.832 :: quick ratio factor
.    x 1.062 =       1634.62 :: short ratio factor
.    x 1.446 =      2363.018 :: EV/R factor
.    x 1.032 =      2438.746 :: price-to-book factor
.    x 4.436 =     10818.467 :: debt-to-revenue factor
.    x 1.003 =     10851.242 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     23013.239 :: sector+industry 1-year gains factor
.    x 1.009 =      23230.21 :: industry 12-weeks return factor
.    x 1.308 =     30382.526 :: industry 2-weeks return factor
.     x 0.97 =     29463.958 :: company one-year gains+dividend factor
.    x 0.973 =     28668.761 :: company 13 weeks' performance factor
.    x 1.117 =     32029.839 :: 50-day avg > 200-day avg
.    x 0.997 =     31933.535 :: "drift" penalty 3 days ago
.    x 0.984 =     31431.558 :: "drift" penalty 5 days ago
.    / 1.896 =     16576.737 :: overall "drift" factor
.    x 0.915 =     15166.613 :: largest single-day jump factor
.        x 1 =     15166.613 :: volatility factor
.        x 1 =     15166.613 :: 42-day volatility factor
.    x 0.488 =      7399.827 :: notable returns + performance factor
.    x 2.514 =     18599.742 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.586 =     10893.035 :: forward EPS factor
.    x 0.849 =      9252.928 :: forward P/E factor
.    x 1.185 =     10962.059 :: industry recommendation factor
.    x 2.927 =     32080.484 :: company recommendation factor
.    x 1.003 =     32169.199 :: factor historical industry gain for week 29
.    x 10.78 =    346770.647 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        24.267 :: reduced for readability
.    + 1.866 =        26.133 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     26.133 :: FINAL WEIGHT for NASDAQ:ALBO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org